Cargando…
Acute pulmonary embolism in COVID-19 related hypercoagulability
Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromb...
Autores principales: | Lorenzo, Cerruti, Francesca, Boscaro, Francesco, Poletto, Elena, Campello, Luca, Spiezia, Paolo, Simioni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260472/ https://www.ncbi.nlm.nih.gov/pubmed/32474757 http://dx.doi.org/10.1007/s11239-020-02160-1 |
Ejemplares similares
-
Correction to: Acute pulmonary embolism in COVID-19 related hypercoagulability
por: Cerruti, Lorenzo, et al.
Publicado: (2020) -
More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared With Other Pneumonia
por: Spiezia, Luca, et al.
Publicado: (2020) -
WITHDRAWN: More Severe Hypercoagulable State in Acute COVID-19 Pneumonia as Compared to Other Oneumonia
por: Spiezia, Luca, et al.
Publicado: (2021) -
Assessing Clinically Meaningful Hypercoagulability after COVID-19 Vaccination: A Longitudinal Study
por: Campello, Elena, et al.
Publicado: (2022) -
Absence of hypercoagulability after nCoV-19 vaccination: An observational pilot study
por: Campello, Elena, et al.
Publicado: (2021)